IRF1 and non-small cell lung carcinoma: Furthermore, the targets of IRF1 and IRF9 expression levels in the IFNγ and STAT3 inhibitor combination group were the highest and the SOCS1 lowest in NSCLC cells (H1299, H1975, PC9, and H3255).